Evidence map›Paper›PMID 41511522›Full record

ArticleArchives of toxicology2026

THP-1-derived polarized macrophages differ by drug transporter transcriptomics, P-glycoprotein activity and rifampicin uptake kinetics.

Katharina Hamburg, Cindy Bay, Jürgen Burhenne, Johanna Weiss, Julia C Stingl, Dirk Theile

Abstract read
In one paragraph

Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katharina HamburgInternal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology Medical Faculty Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Cindy BayInternal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology Medical Faculty Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Jürgen BurhenneInternal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology Medical Faculty Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Johanna WeissInternal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology Medical Faculty Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Julia C StinglInternal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology Medical Faculty Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Dirk TheileInternal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology Medical Faculty Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. dirk.theile@med.uni-heidelberg.de.ORCID 0000-0003-4720-9242

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inferior efficacy of antibiotics (e.g. rifampicin) in M2 macrophage-dominant tuberculosis granuloma might be related to poor drug uptake into these cells, potentially mediated by altered expression and activity of drug transporters such as P-glycoprotein (P-gp, encoded by ABCB1). Consequently, THP-1 cells were differentiated (200 nM phorbol 12-myristate 13-acetate; 72 h) and polarized to M1 (50 ng/mL lipopolysaccharide, 20 ng/mL interferon-gamma; 48 h) or M2 (20 ng/mL interleukin-4, interleukin-13; 48 h) macrophages. Then, quantitative polymerase-chain reaction array-based transcriptional analysis, flow cytometry, and ultra-performance liquid chromatography coupled to tandem mass spectrometry were used to evaluate the impact of differentiation and polarization on the expression levels of 84 drug transporter genes, the efflux activity of P-gp, and the cellular rifampicin uptake kinetics. ABCB1 was enhanced 166-fold during M1 polarization and 55-fold during M2 polarization. P-gp efflux activity in M2 cells was 1.55-fold higher than in M1 cells (P < 0.05). Rifampicin uptake into M2 cells was lower than into M1 cells after 2 h (P < 0.01) or 4 h exposure (P = 0.06) to 0.05 µM rifampicin. Together, when compared to M1 macrophages, M2 cells exhibit a considerably altered fingerprint of drug transporter expression levels, including an enhanced expression and activity of P-gp, being accompanied by lowered rifampicin uptake.

Indexed as

Antibiotics, AntitubercularATP Binding Cassette Transporter, Subfamily B, Member 1MacrophagesRifampinATP Binding Cassette Transporter, Subfamily BCell DifferentiationHumansTHP-1 CellsTranscriptomeABCB1 protein, humanAntibiotics, AntitubercularATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1RifampinDrug transportersMacrophagesP-glycoproteinPolarizationRifampicinTHP-1Tuberculosis

Identifiers

PMID41511522
PMCPMC13043547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.